Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Fosfomycin IV,Salvage therapy for infections caused by carbapenem resistant Enterobacteriaceae (CREs) in adults,Fosfomycin IV,,Hospital,Infections - Agents for Systemic Use
